Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
HMD
vs
S
S&P/ASX 300
HMD
Over the past 12 months, HMD has outperformed S&P/ASX 300, delivering a return of +10% compared to S&P/ASX 300's 4% drop.
Stocks Performance
HMD vs S&P/ASX 300
Performance Gap
HMD vs S&P/ASX 300
Performance By Year
HMD vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
HeraMED Ltd
Glance View
Hera Med Ltd is a digital health company focused on pregnancy care. It makes connected monitoring tools and software that let clinicians track a pregnant patient’s health outside the clinic, with a strong focus on fetal and maternal monitoring. Its best-known product is a handheld fetal heart rate monitor that syncs with a mobile app and cloud software. The company sells its devices and software to hospitals, obstetric clinics, doctors, and other maternity care providers. It also works with health systems that want to monitor patients remotely, which can reduce the need for in-person visits and make it easier to follow pregnancies between appointments. Hera Med makes money by selling hardware, software subscriptions, and related service arrangements. What makes the business different is that it sits between medical device maker and care software provider. It does not just sell a monitor; it also provides the digital workflow around it, so care teams can collect readings, review data, and manage patients in one system. That mix of device sales and recurring software revenue gives it a role in the growing shift toward remote, data-driven maternity care.